Stock listing

TLX Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: TLX · ASX · AUD · AU

TLX:ASX is the primary listing for Telix Pharmaceuticals Limited, an Australian public company with a market capitalization of approximately AUD 3.71 billion. The company specializes in developing and commercializing innovative radiopharmaceuticals aimed at treating cancer and other serious diseases. Telix is committed to enhancing patient outcomes through its targeted therapies and is actively advancing its product pipeline within the healthcare sector. Recent news and filings may provide insights into the company's ongoing developments and market activities.

TLX:ASXAUDAUUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
TLX:ASX
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

Telix Pharmaceuticals Limited TLX:ASX stock context

TLX:ASX is the primary listing for Telix Pharmaceuticals Limited, an Australian public company with a market capitalization of approximately AUD 3.71 billion. The company specializes in developing and commercializing innovative radiopharmaceuticals aimed at treating cancer and other serious diseases. Telix is committed to enhancing patient outcomes through its targeted therapies and is actively advancing its product pipeline within the healthcare sector. Recent news and filings may provide insights into the company's ongoing developments and market activities.

Research Telix Pharmaceuticals Limited

Alternate listings